COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF PREPARING COMPOUNDS AND OF THEIR USE
Disclosed are compounds and pharmaceutically acceptable salts thereof that may be used in the treatment of subjects in need thereof. The compounds disclosed herein may be inhibitors of tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1). Also di
-
Page/Page column 76; 113
(2021/10/11)
METHODS OF USING MYT1 INHIBITORS
Disclosed are methods of using inhibitors of tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1), e.g., in the treatment of subjects in need thereof.
-
Page/Page column 112; 113
(2021/10/11)
The Bromination of Lutidines
-
Dunn, Allan D.,Guillermic, Sandrine
p. 59 - 60
(2007/10/02)
More Articles about upstream products of 117846-56-7